Climb Bio, Inc.

CLYM · Nasdaq · SIC 2834: Pharmaceutical Preparations
83
SEC Filings

Business Summary

PART I . Company Overview We are a clinical-stage biotechnology company committed to developing potential best-in-class therapeutics that address significant unmet need for patients living with immune-mediated diseases. We have built our pipeline by strategically acquiring or in-licensing product candidates that we believe have clear biological rationale, well-defined development pathways, and the potential to address multiple indications. We are developing our product candidates for multiple im...

Next Earnings

Q2 FY2026 — expected 2026-09-23

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCLYMdiscussed_in_filing Cybersecurity
topic_mentionCLYMdiscussed_in_filing Cybersecurity
topic_mentionCLYMdiscussed_in_filing Blockchain & Crypto
topic_mentionCLYMdiscussed_in_filing Healthcare & Bio
topic_mentionCLYMdiscussed_in_filing Blockchain & Crypto
topic_mentionCLYMdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-092546EDGAR99K words
2025-03-252024-12-310000950170-25-044350EDGAR—
2024-03-282023-12-310000950170-24-038023EDGAR—
2023-03-062022-12-310000950170-23-006279EDGAR—
2022-03-072021-12-310000950170-22-002998EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268086EDGAR69K words
2025-08-122025-06-300000950170-25-106916EDGAR—
2025-05-142025-03-310000950170-25-070902EDGAR—
2024-11-122024-09-300000950170-24-125294EDGAR—
2024-08-142024-06-300000950170-24-096626EDGAR—
2024-05-152024-03-310000950170-24-059995EDGAR—
2023-11-142023-09-300000950170-23-063675EDGAR—
2023-08-102023-06-300000950170-23-041303EDGAR—
2023-05-112023-03-310000950170-23-021186EDGAR—
2022-11-142022-09-300000950170-22-024611EDGAR—
2022-08-152022-06-300000950170-22-017181EDGAR—
2022-05-162022-03-310000950170-22-009931EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001193125-26-142114EDGAR1K words
2026-03-050001193125-26-092520EDGAR—
2026-01-080001193125-26-006994EDGAR—
2025-12-310001193125-25-338318EDGAR—
2025-12-110001193125-25-315108EDGAR—
2025-11-060001193125-25-268075EDGAR—
2025-10-170001193125-25-241951EDGAR—
2025-10-010001193125-25-227025EDGAR—
2025-09-290001193125-25-221756EDGAR—
2025-08-120000950170-25-106913EDGAR—

83 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001768446
TickerCLYM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6b0d112423e597dc9d82b0b053817dab93798f155d06e24b9f18a286c9db1a7e
parent: 41d54df8c4686ac50a7d283c4f7023537133fbad18b07809f618d8845df28861
content hash: ad90f508f3fb4733a72838e0480af4e1db7ca5721f96a814fd41c124825b906f
signed: 2026-04-13T04:44:22.597Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf